In conclusion, this study indicates that rSjP40 inhibits the activity of COL1A1 promoter by increasing the expression of transcription factor Ets-1, down-regulating the expression of COL1A1, thereby inhibiting the activation of HSCs and inhibiting liver fibrosis. Here, ETS1 is linked to Hepatic fibrosis.